Literature DB >> 25813818

Burden of varicella in Italy, 2001-2010: analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions.

Cecilia Trucchi1, Giovanni Gabutti2, Maria Cristina Rota3, Antonino Bella3.   

Abstract

Varicella represents the most widespread vaccine-preventable childhood infectious disease in Italy. The purpose of this retrospective study was to assess the burden of varicella in Italy and in three regions that first implemented universal varicella vaccination. Four data sources were analysed: statutory notification data, the National Hospital Discharge Database, mortality data, and the vaccination coverage reached in Sicilia, Veneto and Apulia. The incidence rates per 100,000 population were calculated using the Italian resident population provided by the Italian Institute of Statistics in 2001-2010. In 2001-2010, the mean annual incidence of notifications of varicella was 150.7 cases per 100,000 population, reaching 948.6 cases per 100,000 population in the paediatric age group. The annual incidence declined to 102.6 per 100,000 population in 2010. During the period considered, 20,295 hospitalizations for varicella were observed. The mean annual incidence was 3.4 per 100,000 population, reaching a minimum of 2.5 per 100,000 in 2009 and 2010. Of the hospitalizations, 68.4% occurred in the paediatric age group. The median length of hospital stay was 4 days. During 2001-2003 and 2006-2010, 33 deaths were reported. In the three regions considered, vaccination coverage increased steadily, reaching 81.5% in Sicily, 79.4% in Veneto and 75.6% in Apulia in 2010. During the same period, hospitalization and notification rates decreased significantly. This study demonstrated that varicella continues to represent a relevant health problem in Italy, especially in the paediatric age group. Data obtained from the three Italian regions that first introduced universal vaccination demonstrated that vaccination reduces the incidence of varicella and hospitalization rates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25813818     DOI: 10.1099/jmm.0.000061

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Has VZV epidemiology changed in Italy? Results of a seroprevalence study.

Authors:  Antonella De Donno; Parvanè Kuhdari; Marcello Guido; Maria Cristina Rota; Antonino Bella; Giordana Brignole; Silvia Lupi; Adele Idolo; Armando Stefanati; Martina Del Manso; Giovanni Gabutti
Journal:  Hum Vaccin Immunother       Date:  2016-12-27       Impact factor: 3.452

Review 2.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

3.  Fatal varicella pneumonia in an unvaccinated child with Down Syndrome: a case report.

Authors:  Diletta Valentini; Simona Bianchi; Chiara Di Camillo; Anna Chiara Vittucci; Michaela Veronika Gonfiantini; Rita De Vito; Alberto Villani
Journal:  Ital J Pediatr       Date:  2016-11-17       Impact factor: 2.638

4.  Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.

Authors:  Katsiaryna Holl; Christophe Sauboin; Emanuele Amodio; Paolo Bonanni; Giovanni Gabutti
Journal:  BMC Public Health       Date:  2016-10-21       Impact factor: 3.295

5.  The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies.

Authors:  C Azzari; V Baldo; S Giuffrida; R Gani; E O'Brien; C Alimenti; V J Daniels; L J Wolfson
Journal:  Clinicoecon Outcomes Res       Date:  2020-06-08

Review 6.  Management of chickenpox in pregnant women: an Italian perspective.

Authors:  Serena Parente; Nicola Schiano Moriello; Alberto Enrico Maraolo; Grazia Tosone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-25       Impact factor: 3.267

7.  Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy.

Authors:  Maria Francesca Piazza; Daniela Amicizia; Chiara Paganino; Francesca Marchini; Matteo Astengo; Federico Grammatico; Cecilia Trucchi; Paolo Romairone; Simona Simonetti; Camilla Sticchi; Filippo Ansaldi
Journal:  Vaccines (Basel)       Date:  2021-12-15

8.  Economic burden of varicella in Europe in the absence of universal varicella vaccination.

Authors:  Manjiri Pawaskar; Estelle Méroc; Salome Samant; Elmira Flem; Goran Bencina; Margarita Riera-Montes; Ulrich Heininger
Journal:  BMC Public Health       Date:  2021-12-21       Impact factor: 3.295

9.  Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015.

Authors:  Jacek Wysocki; Ilona Malecka; Joanna Stryczynska-Kazubska; Emmanouil Rampakakis; Barbara Kuter; Lara J Wolfson
Journal:  BMC Public Health       Date:  2018-03-27       Impact factor: 3.295

10.  The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study.

Authors:  Alessia Melegaro; Valentina Marziano; Emanuele Del Fava; Piero Poletti; Marcello Tirani; Caterina Rizzo; Stefano Merler
Journal:  BMC Med       Date:  2018-07-17       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.